Related Experiment Video
Updated: Apr 12, 2026

A 3D Spheroid Model as a More Physiological System for Cancer-Associated Fibroblasts Differentiation and Invasion In Vitro Studies
Published on: August 8, 2019
Calumenin and fibulin-1 on tumor metastasis: Implications for pharmacology
Pengli Zheng1, Qiao Wang1, Junlin Teng1
1State Key Laboratory of Bio-membrane and Membrane Bio-engineering; Key Laboratory of Cell Proliferation and Differentiation of the Ministry of Education, College of Life Sciences, Peking University, Beijing 100871, China.
Abstract:
Tumor metastasis is a key cause of cancer mortality, and inhibiting migration of cancer cells is one of the major directions of anti-metastatic drug development. Calumenin and fibulin-1 are two extracellular proteins that synergistically inhibit cell migration and tumor metastasis, and could potentially be served as targets for pharmacological research of anti-metastatic drugs. This review briefly introduces the multi-function of these two proteins, and discusses the mechanism of how they regulate cell migration and tumor metastasis.
Insights
Calumenin and fibulin-1 are extracellular proteins that work together to stop cancer cell migration and spread. Understanding their function is key for developing new anti-metastatic drugs.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Tumor metastasis significantly contributes to cancer mortality.
- Inhibiting cancer cell migration is a critical goal in anti-metastatic drug development.
Purpose of the Study:
- To review the functions of calumenin and fibulin-1.
- To discuss their synergistic role in inhibiting cell migration and tumor metastasis.
- To explore their potential as targets for anti-metastatic drug research.
Main Methods:
- Literature review of studies on calumenin and fibulin-1.
- Analysis of the mechanisms regulating cell migration and metastasis.
- Synthesis of information on the proteins' extracellular functions.
Main Results:
- Calumenin and fibulin-1 are extracellular proteins with multiple functions.
- These proteins synergistically inhibit cancer cell migration.
- Their combined action suppresses tumor metastasis.
Conclusions:
- Calumenin and fibulin-1 represent promising targets for anti-metastatic drug development.
- Further research into their mechanisms can guide the creation of novel cancer therapies.
More Related Videos
Related Concept Videos
Drugs that Stabilize Microtubules
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
Drugs that Destabilize Microtubules
Destabilization of Microtubules
Cancer Cell Migration through Invadopodia

